Loopbaan van Marie-Noëlle Ip
Eerdere bekende functies van Marie-Noëlle Ip
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BCE INC. | Corporate Officer/Principal | 01-01-2003 | 01-01-2003 |
| Council of Canadian Academies | Corporate Officer/Principal | - | - |
Verlyx Pharma, Inc.
 Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada. | Operationeel Directeur | 01-05-2009 | - |
Statistieken
Internationaal
| Canada | 4 |
Operationeel
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
Sectoraal
| Health Technology | 2 |
| Communications | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BCE INC. | Communications |
| Bedrijven in privébezit | 2 |
|---|---|
Verlyx Pharma, Inc.
Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada. | Health Technology |
| Council of Canadian Academies |
- Beurs
- Insiders
- Marie-Noëlle Ip
- Ervaring
